1. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013;122(4):491-498.
  2. Rocha V, Chastang C, Souillet G, et al. Related cord blood transplants: The Eurocord experience from 78 transplants. Eurocord Transplant group. Bone Marrow Transplant 1998;21(Suppl 3):S59-S62.
  3. U.S. Food and Drug Administration. Cord Blood Banking — Information for Consumers. Available at www.fda.gov/BiologicsBloodVaccines/ResourcesforYou/Consumers/ucm236044.htm
  4. Saccardi R, Tucunduva L, Ruggeri A, et al. Impact of cord blood banking technologies on clinical outcome: A Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis. Transfusion 2016;56:2021-2029.
  5. New York Blood Center. National Cord Blood Program. Available at: http://www.nationalcordbloodprogram.org/
  6. Gragert G, Eapen M, Williams E. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. New Engl J Med 2014;371:339-348.
  7. Juric MK, Sakhila G, Ogonek J, et al. Milestones of hematopoietic stem cell transplantation — from first human studies to current developments. Frontiers Immunol 2016;7:470, doi:10.3389/fimmu.2016.00470
  8. Graft-versus-host disease. Medline Plus. Available at: https://medlineplus.gov/ency/article/001309.htm
  9. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells — current trends and future prospective. Biosci Reports 2015;35;e00191, doi:10.1042/BSR20150025
  10. Omar RE, Beroud J, Stoltz J-F. Umbilical cord mesenchymal stem cells: The new gold standard for mesenchymal stem cell-based therapies. Tissue Eng 2014;20(5):523-544.
  11. Wei X, Yang X, Han Z, et al. Mesenchymal stem cells: A new trend for cell therapy. Acta Pharm Sinica 2013;34:747-754.
  12. Cord Blood Organization. History of Cord Blood. Available at http://cord-blood.org.uk/history-of-cord-blood/
  13. Gluckman E. History of cord blood transplantation. Bone Marrow Trans 2009;44:621-626.
  14. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-1178.
  15. Wagner JE, Broxmeyer HE, Byrd RL. Transplantation of umbilical cord blood after myeloablative therapy: Analysis of engraftment. Blood 1992;79:1874-1881.
  16. Laporte J-P, Gorin N-C, Rubinstein P, et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N Engl J Med 1996;335(3):167-170.
  17. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335(3):157-166.
  18. Brichard B, Vermylen C, Ninane J, Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 1996;128(2):241-243.
  19. Rocha V, Wagner Jr JE, Sobocinski KA. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000;342(25):1846-1854.
  20. Banking Cord Blood. Cord blood bank accreditation standards. www.bankingcordblood.org/cord-blood-bank-accreditation.
  21. AABB. AABB accredited cord blood (CB) facilities. www.aabb.org/sa/facilities/celltherapy/Pages/cordbloodfaqs.aspsx#4
  22. FACT. What FACT accreditation means to patients and their families. www.factwebsite.org
  23. Armitage S. Cord blood banking standards: autologous versus altruistic. Frontiers in Med 2016;2:94, doi:10.3389/med.2015.00094
  24. Broxmeyer HE, Lee M-R, Hangoc G, Cooper S, et al. Hematopoietic stem-progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 2011;117:4773-4777.
  25. Kurtzberg J, Lyerly AD, Sugarman J. Untying the Gordian know: Policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest 2005;115(10):2592-2597.
  26. Wagner JE, Eapen M, Carter S, et al. One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers. N Engl J Med 2014;371:1685-1694.
  27. Interview with Joanne Kurtzberg, MD. Available at http://www.stembook.org/node/5659.html
  28. Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 2013;121(5):752-758.
  29. Tse WW, Zang SL, Bunting KD, Laughlin MJ. Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transpl 2008;41:465-472.
  30. Berglund S, Okas M, Gertow J, et al. Stable mixed donor-donor chimerism after double cord blood transplantation. Int J Hematol 2009;90:526.
  31. Choudhery MS, Badowski M, Muise A, Harris DT. Utility of cryopreserved umbilical cord tissue for regenerative medicine. Curr Stem Cell Res Ther 2013;8(5):370-380.